Literature DB >> 2661071

Oral parameters in the diagnosis of Sjögren's syndrome.

C Scully1.   

Abstract

Xerostomia is the main oral symptom and clinical sign in Sjögren's syndrome (SS) but there are many other causes of a dry mouth. Salivary gland enlargement is a further feature but may be episodic. Xerostomia is a subjective symptom which can be non-invasively assessed by sialometry but this is too variable, insensitive and non-specific to be diagnostic of SS. Sialochemistry, though conceptually appealing is nondiscriminatory and of little diagnostic value. Sialographic changes in SS are not specific and generally regarded as insensitive, though this has recently been questioned. Salivary scintigraphy may be of some value because it is relatively non-invasive and examines all glands simultaneously and over a period of time; but it is non-specific. Lower labial salivary gland biopsy gives more specific diagnostic information than most other investigations but must be carried out and interpreted using strict criteria.

Entities:  

Mesh:

Year:  1989        PMID: 2661071

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

1.  Measurement of whole unstimulated salivary flow in the diagnosis of Sjögren's syndrome.

Authors:  P M Speight; A Kaul; R D Melsom
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

2.  The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome.

Authors:  C Vitali; H M Moutsopoulos; S Bombardieri
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

3.  The diagnostic value of salivary fluid levels of beta 2-microglobulin, lysozyme and lactoferrin for primary Sjögren's syndrome.

Authors:  H M Markusse; H G Otten; T M Vroom; T J Smeets; N Fokkens; F C Breedveld
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

4.  The diagnosis value of beta 2-microglobulin and immunoglobulins in primary Sjögren's syndrome.

Authors:  S Maddali Bongi; G Campana; A D'Agata; C Palermo; G Bianucci
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.